201 related articles for article (PubMed ID: 16913315)
41. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms.
Austin F; Mavanur A; Sathaiah M; Steel J; Lenzner D; Ramalingam L; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2012 May; 19(5):1386-93. PubMed ID: 22302270
[TBL] [Abstract][Full Text] [Related]
42. Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.
Stamou KM; Karakozis S; Sugarbaker PH
J Surg Oncol; 2003 Aug; 83(4):197-203. PubMed ID: 12884230
[TBL] [Abstract][Full Text] [Related]
43. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
44. Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer.
Turner KM; Hanna NN; Zhu Y; Jain A; Kesmodel SB; Switzer RA; Taylor LM; Richard Alexander H
Ann Surg Oncol; 2013 Apr; 20(4):1068-73. PubMed ID: 23456383
[TBL] [Abstract][Full Text] [Related]
45. CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Valle SJ; Alzahrani N; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Dec; 43(12):2299-2307. PubMed ID: 28993033
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of regional treatment for peritoneal carcinomatosis.
Lanuke K; Mack LA; Temple WJ
Am J Surg; 2009 May; 197(5):614-8; discussion 618. PubMed ID: 19393354
[TBL] [Abstract][Full Text] [Related]
47. Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival.
Cashin P; Nygren P; Hellman P; Granberg D; Andréasson H; Mahteme H
Clin Colorectal Cancer; 2011 Jun; 10(2):108-12. PubMed ID: 21859562
[TBL] [Abstract][Full Text] [Related]
48. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin.
Bruin SC; Verwaal VJ; Vincent A; van't Veer LJ; van Velthuysen ML
Ann Surg Oncol; 2010 Sep; 17(9):2330-40. PubMed ID: 20232161
[TBL] [Abstract][Full Text] [Related]
49. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.
Misdraji J; Yantiss RK; Graeme-Cook FM; Balis UJ; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1089-103. PubMed ID: 12883241
[TBL] [Abstract][Full Text] [Related]
50. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
51. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management.
Jacquet P; Vidal-Jove J; Zhu B; Sugarbaker P
Acta Chir Belg; 1994; 94(4):191-7. PubMed ID: 8053288
[TBL] [Abstract][Full Text] [Related]
52. Epithelial appendiceal neoplasms.
Sugarbaker PH
Cancer J; 2009; 15(3):225-35. PubMed ID: 19556909
[TBL] [Abstract][Full Text] [Related]
53. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
[TBL] [Abstract][Full Text] [Related]
54. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
55. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
56. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
[TBL] [Abstract][Full Text] [Related]
57. Discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination.
Yan TD; Brun EA; Sugarbaker PH
Ann Surg Oncol; 2008 May; 15(5):1440-6. PubMed ID: 18299936
[TBL] [Abstract][Full Text] [Related]
58. The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer.
Jimenez WA; Sardi A; Ledakis P; Nieroda C; Sittig M; Gushchin V
Eur J Surg Oncol; 2013 Dec; 39(12):1415-22. PubMed ID: 24075030
[TBL] [Abstract][Full Text] [Related]
59. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450
[TBL] [Abstract][Full Text] [Related]
60. Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis.
Foster JM; Sleightholm RL; Wahlmeier S; Loggie B; Sharma P; Patel A
World J Surg Oncol; 2016 Sep; 14(1):243. PubMed ID: 27619776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
